Eosinophil Induced Remodelling in Asthma (ERA)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02648074|
Recruitment Status : Unknown
Verified January 2016 by Kestutis Malakauskas, Lithuanian University of Health Sciences.
Recruitment status was: Recruiting
First Posted : January 6, 2016
Last Update Posted : January 6, 2016
Lithuanian University of Health Sciences
Research Council of Lithuania
University of Groningen
Information provided by (Responsible Party):
Kestutis Malakauskas, Lithuanian University of Health Sciences
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Estimated Primary Completion Date :||October 2016|
|Estimated Study Completion Date :||January 2017|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Januskevicius A, Gosens R, Sakalauskas R, Vaitkiene S, Janulaityte I, Halayko AJ, Hoppenot D, Malakauskas K. Suppression of Eosinophil Integrins Prevents Remodeling of Airway Smooth Muscle in Asthma. Front Physiol. 2017 Jan 9;7:680. doi: 10.3389/fphys.2016.00680. eCollection 2016.
Januskevicius A, Vaitkiene S, Gosens R, Janulaityte I, Hoppenot D, Sakalauskas R, Malakauskas K. Eosinophils enhance WNT-5a and TGF-β1 genes expression in airway smooth muscle cells and promote their proliferation by increased extracellular matrix proteins production in asthma. BMC Pulm Med. 2016 Jun 13;16(1):94. doi: 10.1186/s12890-016-0254-9.